Open tender · Germany · Pharmaceutical products
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1a (ausschl. z. intramuskulären Injektion), ATC L03AB07 für die Zeit 01.05.2025 - 30.04.2027
In EnglishConclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Interferon beta-1a (excl. for intramuscular injection), ATC L03AB07 for the period 01.05.2025 - 30.04.2027
DAK-Gesundheit in Germany is inviting bids for “Conclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Interferon beta-1a (excl”. Bids close on 5 March 2027, 12:00 CET. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Conclusion of a non-exclusive discount agreement for the active substance Interferon beta-1a (excl. intramuscular injection), ATC L03AB07, for the period 01.05.2025 - 30.04.2027.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 2 requirements to qualify (1 on experience, 1 certifications and registrations) and the 4 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences